European Medicines Agency– tag –
-
HCA Healthcare Announces Promising Results for CRISPR Gene Therapy Exa-cel in Pediatric Sickle Cell Disease and Beta-Thalassemia Patients
HCA Healthcare USA Overview HCA Healthcare has announced findings from a New England Journal of Medicine study, sponsored by Vertex Pharmaceuticals, demonstrating that the CRISPR gene-editing therapy exa-cel shows promising results in pe... -
Data Integrity in Bioprocessing: ALCOA+ Compliance Critical for Ensuring Reliability of GMP Records
Lab Manager Global Overview In bioprocessing labs, data integrity and adherence to ALCOA+ principles are critical for meeting regulatory expectations and ensuring product safety and efficacy. All GMP records, including those from bioreac... -
Real-Time Monitoring Tools Advance Bioreactor Scale-Up, Integrating Digital Twins and PAT for Enhanced Efficiency
Cellbase Global Overview To efficiently scale up bioreactors, real-time monitoring tools—including electrochemical and optical sensors, PAT instruments like Raman and NIR spectroscopy, and capacitance probes for live cell density—are rap... -
Raman Spectroscopy Outperforms NIR in Bioprocess Monitoring, Offering Enhanced Metabolite Selectivity with Reduced Water Interference
Technology Networks Global Overview In real-time bioprocess monitoring, Raman spectroscopy demonstrates superior selectivity for metabolites like glucose and lactate in cell cultures compared to Near-Infrared (NIR) spectroscopy, due to i... -
Genedata Establishes New Standard for Biopharma Quality Control with NGS, Ensuring Genetic Stability in CGT
Genedata Switzerland Overview Genedata highlights Next-Generation Sequencing (NGS) as a powerful analytical tool for biopharmaceutical quality control (QC). NGS offers GxP-compliant workflows and supports data integrity and streamlined c... -
Data Integrity and ALCOA+ Compliance Critical for Bioprocessing Lab Managers: Addressing Regulatory Requirements with Digital Solutions
LabManager.com USA Overview An article highlights the critical importance of data integrity and ALCOA+ compliance for bioprocessing lab managers. Maintaining ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, C... -
WuXi Biologics Suzhou BioSafety Testing Center Secures Fourth EMA GMP Certification, Enabling 19 Commercial Products for European Market
WuXi Biologics China Overview WuXi Biologics' Suzhou BioSafety Testing Center has successfully renewed its European Medicines Agency (EMA) GMP certification for the fourth time. This accreditation enables the center to support quality te... -
Medyra Health Bolsters Therapeutic Development and Evaluation by Leveraging Real-World Evidence (RWE)
Medyra Health USA Overview Medyra Health outlines its RWE-focused therapeutic approach, emphasizing the generation of high-quality real-world evidence to enhance therapy evaluation and development. The company specializes in RWE study de... -
EMA Confirms Acceptance of Marketing Authorization Application for Novel Early Alzheimer’s Drug Candidate
PharmaNews Europe Europe Overview The European Medicines Agency (EMA) has confirmed acceptance of a Marketing Authorization Application (MAA) for a novel drug candidate targeting early Alzheimer's disease. The application includes pivota... -
Daiichi Sankyo and AstraZeneca’s Gastric Cancer ADC Receives Positive EMA CHMP Opinion for Approval
European Medicines Agency (EMA) Europe Overview The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending approval for an antibody-drug conjugate (ADC) develo...
